1. Home
  2. AKA vs SERA Comparison

AKA vs SERA Comparison

Compare AKA & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo a.k.a. Brands Holding Corp.

AKA

a.k.a. Brands Holding Corp.

HOLD

Current Price

$9.62

Market Cap

113.4M

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$2.28

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKA
SERA
Founded
2018
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.4M
75.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
AKA
SERA
Price
$9.62
$2.28
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$24.33
N/A
AVG Volume (30 Days)
4.4K
55.2K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.32
EPS
N/A
N/A
Revenue
$600,208,000.00
$81,000.00
Revenue This Year
$6.14
$554.81
Revenue Next Year
$4.89
$517.27
P/E Ratio
N/A
N/A
Revenue Growth
4.44
5.19
52 Week Low
$8.60
$1.37
52 Week High
$16.38
$4.09

Technical Indicators

Market Signals
Indicator
AKA
SERA
Relative Strength Index (RSI) 40.00 60.53
Support Level $8.94 $1.73
Resistance Level $11.83 $2.41
Average True Range (ATR) 0.60 0.25
MACD -0.20 0.05
Stochastic Oscillator 11.18 71.63

Price Performance

Historical Comparison
AKA
SERA

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: